AmideBio's Grant

AmideBio raised a round of funding on September 28, 2017. Investors include National Institutes of Health.

AmideBio is a biotechnology company focused on providing peptide and protein research reagents and clinical products for a diverse array of research and commercial targets. AmideBio addresses the chal…

Articles about AmideBio's Grant: